Cogent Biosciences, Inc. · NASDAQ:COGT
Commodore Capital LP reported a 7.20% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Commodore Capital LP reported a 7.20% stake in Cogent Biosciences, Inc., 10,208,060 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 10,208,060
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 7.20% | 10,208,060 |
| Commodore Capital Master LP | 7.20% | 10,208,060 |
| Robert Egen Atkinson | 7.20% | 10,208,060 |
| Michael Kramarz | 7.20% | 10,208,060 |
Source
Related
- Cogent Biosciences, Inc.
- Commodore Capital LP
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2025
- Schedule 13G · Commodore Capital LP · Aug 14, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026